Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 1476-5551

Journal

More filtering options
  1. 2021
  2. BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib

    H. Yesid Estupiñán, Qing Wang, Anna Berglöf, Gerard C.P. Schaafsma, Yuye Shi, Litao Zhou, Dara K. Mohammad, Liang Yu, Mauno Vihinen, Rula Zain & C. I.Edvard Smith, 2021 Feb 1, In: Leukemia.

    Research output: Contribution to journalArticle

  3. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

    Michael Grever, Leslie Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema Bhat, James S. Blachly, Timothy Call, Matthew Cross, Claire Dearden, Judit Demeter, Sasha Dietrich, Brunangelo Falini, Francesco Forconi, Douglas E. Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B. Johnston, Gunnar Juliusson, Eric Kraut, Robert J. Kreitman & 19 others, Francesco Lauria, Gerard Lozanski, Sameer A. Parikh, Jae Park, Aaron Polliack, Farhad Ravandi, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Enrico Tiacci, Xavier Troussard, Clive Zent, Thorsten Zenz, Pier Luigi Zinzani & Bernhard Wörmann, 2021, In: Leukemia.

    Research output: Contribution to journalReview article

  4. 2020
  5. S100A6 is a critical regulator of hematopoietic stem cells.

    Hooi Min Tan Grahn, Abhishek Niroula, Akos Vegvari, Leal Oburoglu, Maroulio Pertesi, Sarah Warsi, Fatemeh Safi, Natsumi Miharada, Sandra C. Garcia, Kavitha Siva, Yang Liu, Emma Rörby, Björn Nilsson, Roman A. Zubarev & Stefan Karlsson, 2020 Jun 19, In: Leukemia.

    Research output: Contribution to journalArticle

  6. Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

    Gerald G. Wulf, Bettina Altmann, Marita Ziepert, Francesco D’Amore, Gerhard Held, Richard Greil, Olivier Tournilhac, Thomas Relander, Andreas Viardot, Martin Wilhelm, Christian Wilhelm, Antonio Pezzutto, Josee M. Zijlstra, Eric Van Den Neste, Pieternella J. Lugtenburg, Jeanette K. Doorduijn, Michel van Gelder, Gustaaf W. van Imhoff, Florian Zettl, Friederike Braulke & 9 others, Maike Nickelsen, Bertram Glass, Andreas Rosenwald, Philippe Gaulard, Markus Loeffler, Michael Pfreundschuh, Norbert Schmitz, Lorenz Trümper & ACT-2 study investigators ACT-2 study investigators, 2020 May 7, In: Leukemia.

    Research output: Contribution to journalArticle

  7. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    A. Hochhaus, M. Baccarani, R. T. Silver, C. Schiffer, J. F. Apperley, F. Cervantes, R. E. Clark, J. E. Cortes, M. W. Deininger, F. Guilhot, H. Hjorth-Hansen, T. P. Hughes, J. J.W.M. Janssen, H. M. Kantarjian, D. W. Kim, R. A. Larson, J. H. Lipton, F. X. Mahon, J. Mayer, F. Nicolini & 14 others, D. Niederwieser, F. Pane, J. P. Radich, D. Rea, J. Richter, G. Rosti, P. Rousselot, G. Saglio, S. Saußele, S. Soverini, J. L. Steegmann, A. Turkina, A. Zaritskey & R. Hehlmann, 2020 Apr, In: Leukemia. 34, 4, p. 966-984 19 p.

    Research output: Contribution to journalReview article

  8. Genetic predisposition for multiple myeloma

    Maroulio Pertesi, Molly Went, Markus Hansson, Kari Hemminki, Richard S. Houlston & Björn Nilsson, 2020 Mar, In: Leukemia. 34, 3, p. 697-708 12 p.

    Research output: Contribution to journalReview article

  9. 2019
  10. Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance

    Subhayan Chattopadhyay, Hauke Thomsen, Niels Weinhold, Iman Meziane, Stefanie Huhn, Miguel Inacio da Silva Filho, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Roman Hajek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno & 9 others, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O Schönland, Richard Houlston, Hartmut Goldschmidt, Kari Hemminki & Asta Försti, 2019 Nov 6, In: Leukemia. p. 1-5

    Research output: Contribution to journalLetter

  11. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study

    Maria Thastrup, Hanne Vibeke Marquart, Mette Levinsen, Kathrine Grell, Jonas Abrahamsson, Birgitte Klug Albertsen, Thomas Leth Frandsen, Arja Harila-Saari, Päivi Maria Lähteenmäki, Riitta Niinimäki, Cornelis Jan Pronk, Aina Ulvmoen, Goda Vaitkevičienė, Mervi Taskinen, Kjeld Schmiegelow, Peder Wehner, on behalf of the Nordic Society of Pediatric Hematology and Oncology (NOPHO) on behalf of the Nordic Society of Pediatric Hematology and Oncology (NOPHO), Britt Marie Frost, Ulrika Norén-Nyström, Mikael Behrendtz & 3 others, Bendik Lund, Jouni Pesola & Dorota Malgorzata Wojcik, 2019 Sep 18, In: Leukemia.

    Research output: Contribution to journalArticle

  12. Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism

    James B. Studd, Minjun Yang, Zhenhua Li, Jayaram Vijayakrishnan, Yi Lu, Allen Eng Juh Yeoh, Kajsa Paulsson & Richard S. Houlston, 2019 Jan, In: Leukemia. 33, 1, p. 1-14

    Research output: Contribution to journalArticle

  13. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Maroulio Pertesi, Björn Nilsson, James D. McKay, C. Dumontet & et al. et al., 2019, In: Leukemia. 33, 9, p. 2324-2330

    Research output: Contribution to journalLetter

  14. FLT3 N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis

    Axel Hyrenius-Wittsten, Mattias Pilheden, Antoni Falqués-Costa, Mia Eriksson, Helena Sturesson, Pauline Schneider, Priscilla Wander, Cristian Garcia-Ruiz, Jian Liu, Helena Ågerstam, Anne Hultquist, Henrik Lilljebjörn, Ronald W. Stam, Marcus Järås & Anna K. Hagström-Andersson, 2019, In: Leukemia. 33, 9, p. 2310-2314

    Research output: Contribution to journalLetter

  15. Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma

    Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M. Nöthen, Karl Heinz Jöckel, Christian Langer, Roman Hajek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Florentin Späth, Richard Houlston, Hartmut Goldschmidt, Kari Hemminki & Asta Försti, 2019, In: Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 5 p.

    Research output: Contribution to journalLetter

  16. 2018
  17. Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2

    Anna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, Michelle Kung, Emily Ness, Mariel Parman, Liton Francisco, Lindsey Hageman, Kevin Battles, Ravi Bhatia, Donna Salzman, Jeanette Falck Winther, Joseph Rosenthal, Stephen J. Forman, Daniel J. Weisdorf, Saro H. Armenian, Mukta Arora & Smita Bhatia, 2018 Dec, In: Leukemia. 32, 12, p. 2706-2709

    Research output: Contribution to journalArticle

  18. Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    S. Rule, W. Jurczak, M. Jerkeman, C. Rusconi, M. Trneny, F. Offner, D. Caballero, C. Joao, M. Witzens-Harig, G. Hess, I. Bence-Bruckler, S. G. Cho, C. Thieblemont, W. Zhou, T. Henninger, J. Goldberg, J. Vermeulen & M. Dreyling, 2018 Aug, In: Leukemia. 32, 8, p. 1799-1803

    Research output: Contribution to journalArticle

  19. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies

    Josef Davidsson, Andreas Puschmann, Ulf Tedgård, David Bryder, Lars Nilsson & Jörg Cammenga, 2018 May, In: Leukemia. 32, 5, p. 1106-1115

    Research output: Contribution to journalArticle

  20. Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia

    Rebeqa Gunnarsson, Sebastian Dilorenzo, Kristina B. Lundin-Ström, Linda Olsson, Andrea Biloglav, Henrik Lilljebjörn, Marianne Rissler, Per Wahlberg, Anders Lundmark, Anders Castor, Mikael Behrendtz, Thoas Fioretos, Kajsa Paulsson, Anders Isaksson & Bertil Johansson, 2018, In: Leukemia. 32, 10, p. 2117-2125

    Research output: Contribution to journalArticle

  21. 2017
  22. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: Comparison with myeloma

    M. I. Da Silva Filho, A. Försti, N. Weinhold, I. Meziane, C. Campo, S. Huhn, J. Nickel, P. Hoffmann, M. M. Nöthen, K. H. Jöckel, S. Landi, J. S. Mitchell, D. Johnson, G. J. Morgan, R. Houlston, H. Goldschmidt, A. Jauch, P. Milani, G. Merlini, D. Rowcieno & 6 others, P. Hawkins, U. Hegenbart, G. Palladini, A. Wechalekar, S. O. Schönland & K. Hemminki, 2017 Aug 1, In: Leukemia. 31, 8, p. 1735-1742 8 p.

    Research output: Contribution to journalArticle

  23. No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: A population-based study in Sweden

    Niklas Gunnarsson, M. Höglund, L Stenke, F. Sandin, M Björkholm, Arta Dreimane, M. Lambe, Berit Markevärn, Ulla Olsson-Strömberg, Hans Wadenvik, J. Richter & Anders Själander, 2017 Aug 1, In: Leukemia. 31, 8, p. 1825-1827 3 p.

    Research output: Contribution to journalLetter

  24. Early death rates remain high in high-risk APL: Update from the Swedish Acute Leukemia Registry 1997-2013

    S. Lehmann, S. Deneberg, P. Antunovic, Rangert-Derolf, H. Garelius, V. Lazarevic, K. Myhr-Eriksson, L. Möllgård, B. Uggla, A. Wahlin, L. Wennström, M. Höglund & G. Juliusson, 2017 Jun 1, In: Leukemia. 31, 6, p. 1457-1459

    Research output: Contribution to journalLetter

  25. Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

    M. Ilander, U. Olsson-Strömberg, H. Schlums, J. Guilhot, O. Brück, H. Lähteenmäki, T. Kasanen, P. Koskenvesa, S. Söderlund, M. Höglund, B. Markevärn, A. Själander, K. Lotfi, A. Dreimane, A. Lübking, E. Holm, M. Björeman, S. Lehmann, L. Stenke, L. Ohm & 11 others, T. Gedde-Dahl, W. Majeed, H. Ehrencrona, S. Koskela, S. Saussele, F. X. Mahon, K. Porkka, H. Hjorth-Hansen, Y. T. Bryceson, J. Richter & S. Mustjoki, 2017 May 1, In: Leukemia. 31, 5, p. 1108-1116 9 p.

    Research output: Contribution to journalArticle

  26. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1

    Jayaram Vijayakrishnan, R. Kumar, M. Y.R. Henrion, A V Moorman, P Sivaramakrishna Rachakonda, Ismail Hosen, M. I. Da Silva Filho, A Holroyd, Sara E. Dobbins, Rolf Koehler, H. Thomsen, Julie A Irving, J M Allan, Tracy Lightfoot, Erika Roman, Sally E Kinsey, Eamonn Sheridan, P. D. Thompson, P Hoffmann, M M Nöthen & 9 others, Stefanie Heilmann-Heimbach, Karl-Heinz Jöckel, M. W. Greaves, C J Harrison, C R Bartram, Martin Schrappe, Martin Stanulla, K. Hemminki & R S Houlston, 2017 Mar 1, In: Leukemia. 31, 3, p. 573-579 7 p.

    Research output: Contribution to journalArticle

  27. Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

    G. Juliusson, J. Abrahamsson, V. Lazarevic, P. Antunovic, Derolf, H. Garelius, S. Lehmann, K. Myhr-Eriksson, L. Möllgård, B. Uggla, A. Wahlin, L. Wennström & M. Höglund, 2017 Mar 1, In: Leukemia. 31, 3, p. 728-731 4 p.

    Research output: Contribution to journalLetter

  28. Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia

    P. Jaako, A. Ugale, M. Wahlestedt, Talia Velasco, J. Cammenga, M. S. Lindström & D. Bryder, 2017 Jan, In: Leukemia. 31, 1, p. 213-221

    Research output: Contribution to journalArticle

  29. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    M. A. Dimopoulos, E Kastritis, E Terpos, H Nahi, H. Goldschmidt, J Hillengass, X Leleu, Meral Beksac, M Alsina, Albert Oriol, M. Cavo, E. M. Ocio, M. V. Mateos, E K O'Donnell, R Vij, Henk M Lokhorst, Niels W C J van de Donk, J. Cam-min, Torrance Mark, I Turesson & 21 others, Markus Hansson, S. Jagannath, M Delforge, Charalampia Kyriakou, P Hari, U. H. Mellqvist, S Z Usmani, D Dytfeld, Ashraf Z Badros, P R Otero, C Shustik, D Waller, W-J Chng, Shoichi Ozaki, Javier de la Rubia, H S Eom, L Rosinol, J. J. Lahuerta, A Sureda, J. S. Kim & B. G. M. Durie, 2017, In: Leukemia. 31, p. 2443-2448

    Research output: Contribution to journalArticle

  30. 2016
  31. High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists

    V. De Stefano, M. Ruggeri, F. Cervantes, A. Alvarez-Larran, A. Iurlo, M. L. Randi, E. Elli, M. C. Finazzi, G. Finazzi, E. Zetterberg, N. Vianelli, G. Gaidano, E. Rossi, S. Betti, I. Nichele, D. Cattaneo, M. Palova, M. H. Ellis, R. Cacciola, A. Tieghi & 11 others, J. C. Hernandez-Boluda, E. Pungolino, G. Specchia, D. Rapezzi, A. Forcina, C. Musolino, A. Carobbio, M. Griesshammer, E. Sant'Antonio, A. M. Vannucchi & T. Barbui, 2016 Oct 1, In: Leukemia. 30, 10, p. 2032-2038 7 p.

    Research output: Contribution to journalArticle

  32. Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

    H. Hjorth-Hansen, J. Stentoft, J. Richter, P. Koskenvesa, M. Höglund, A. Dreimane, K. Porkka, T. Gedde-Dahl, B. T. Gjertsen, F. X. Gruber, L. Stenke, K. M. Eriksson, B. Markevärn, A. Lübking, H. Vestergaard, L. Udby, O. W. Bjerrum, I. Persson, S. Mustjoki & U. Olsson-Strömberg, 2016 Sep 1, In: Leukemia. 30, 9, p. 1853-1860 8 p.

    Research output: Contribution to journalArticle

  33. Harmonemia: A universal strategy for flow cytometry immunophenotyping - A European LeukemiaNet WP10 study

    F. Lacombe, E. Bernal, D. Bloxham, S. Couzens, M. G.D. Porta, U. Johansson, W. Kern, M. Macey, T. Matthes, R. Morilla, A. Paiva, C. Palacio, F. Preijers, R. Ratei, S. Siitonen, K. Allou, A. Porwit & M. C. Béné, 2016 Aug 1, In: Leukemia. 30, 8, p. 1769-1772 4 p.

    Research output: Contribution to journalLetter

  34. The concept of treatment-free remission in chronic myeloid leukemia

    S. Saußele, J. Richter, A. Hochhaus & F. X. Mahon, 2016 Aug 1, In: Leukemia. 30, 8, p. 1638-1647 10 p.

    Research output: Contribution to journalReview article

  35. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia

    N. Gunnarsson, M. Höglund, L. Stenke, S. Wallberg-Jonsson, F. Sandin, M. Björkholm, A. Dreimane, M. Lambe, B. Markevärn, U. Olsson-Strömberg, H. Wadenvik, J. Richter & A. Själander, 2016 Jul 1, In: Leukemia. 30, 7, p. 1562-1567 6 p.

    Research output: Contribution to journalArticle

  36. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.

    M Fallah, E Kharazmi, E Pukkala, S Tretli, J H Olsen, L Tryggvadottir, Kristina Sundquist & Kari Hemminki, 2016, In: Leukemia. 30, p. 373-378

    Research output: Contribution to journalArticle

  37. Genetic factors influencing the risk of multiple myeloma bone disease.

    D C Johnson, N Weinhold, J Mitchell, B Chen, O W Stephens, Asta Försti, J Nickel, M Kaiser, W A Gregory, D Cairns, G H Jackson, P Hoffmann, M M Noethen, J Hillengass, U Bertsch, B Barlogie, F E Davis, Kari Hemminki, H Goldschmidt, R S Houlston & 1 others, G J Morgan, 2016, In: Leukemia. 30, p. 883-888

    Research output: Contribution to journalArticle

  38. Management of relapsed multiple myeloma: Recommendations of the international myeloma working group.

    J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, P Voorhees, X Leleu, H E Johnsen, M Streetly, H Ludwig, U-H Mellqvist, W-J Chng, L Pilarski, H Einsele, J Hou, Ingemar Turesson, E Zamagni, J Chim, A Mazumder & 16 others, J Westin, J Lu, T Reiman, S Kristinsson, D Joshua, M Roussel, P O'Gorman, E Terpos, M Dimopoulos, P Moreau, K Anderson, A Palumbo, S Kumar, V Rajkumar, B Durie & P Richardson, 2016, In: Leukemia. 30, p. 1005-1017

    Research output: Contribution to journalReview article

  39. Search for familial clustering of multiple myeloma with any cancer.

    C Frank, M Fallah, T Chen, E K Mai, Jan Sundquist, Asta Försti & Kari Hemminki, 2016, In: Leukemia. 30, p. 627-632

    Research output: Contribution to journalArticle

  40. 2015
  41. A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real time quantitative PCR.

    H White, L Deprez, P Corbisier, V Hall, F Lin, S Mazoua, S Trapmann, A Aggerholm, H Andrikovics, S Akiki, G Barbany, N Boeckx, A Bench, M Catherwood, J-M Cayuela, S Chudleigh, T Clench, D Colomer, F Daraio, S Dulucq & 51 others, J Farrugia, L Fletcher, L Foroni, R Ganderton, G Gerrard, E Gineikienė, S Hayette, H El Housni, B Izzo, M Jansson, Petra Johnels, T Jurcek, V Kairisto, A Kizilors, D-W Kim, T Lange, T Lion, K M Polakova, G Martinelli, S McCarron, P A Merle, B Milner, G Mitterbauer-Hohendanner, M Nagar, G Nickless, J Nomdedéu, D A Nymoen, E O Leibundgut, U Ozbek, T Pajič, H Pfeifer, C Preudhomme, K Raudsepp, G Romeo, T Sacha, R Talmaci, T Touloumenidou, V H J Van der Velden, P Waits, L Wang, E Wilkinson, G Wilson, D Wren, R Zadro, J Ziermann, K Zoi, M C Müller, A Hochhaus, H Schimmel, N C P Cross & H Emons, 2015, In: Leukemia. 29, 2, p. 369-376

    Research output: Contribution to journalArticle

  42. A novel Lin-CD34+CD38-integrin α2- bipotential megakaryocyte-erythrocyte progenitor population in human bone marrow.

    Wan Man Wong, M Dolinska, Mikael Sigvardsson, Marja Ekblom & H Qian, 2015, In: Leukemia. 30, p. 1399-1402

    Research output: Contribution to journalArticle

  43. Cellular origin of prognostic chromosomal aberrations in AML patients.

    H Mora-Jensen, Johan Jendholm, N Rapin, M Klarskov Andersen, A S Roug, F Otzen Bagger, L Bullinger, O Winther, N Borregaard, B T Porse & Kim Theilgaard-Moench, 2015, In: Leukemia. 29, 8, p. 1785-1789

    Research output: Contribution to journalLetter

  44. Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement.

    M Bardini, P S Woll, L Corral, S Luc, Lilian Wittmann, Zhi Ma, L Lo Nigro, G Basso, A Biondi, G Cazzaniga & Sten Eirik W Jacobsen, 2015, In: Leukemia. 29, 1, p. 38-50

    Research output: Contribution to journalArticle

  45. Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.

    G P Sava, H E Speedy, M C Di Bernardo, M J S Dyer, A Holroyd, N J Sunter, H Marr, L Mansouri, S Deaglio, L Karabon, I Frydecka, K Jamroziak, D Woszczyk, Gunnar Juliusson, K E Smedby, S Jayne, A Majid, Y Wang, C Dearden, A G Hall & 14 others, T Mainou-Fowler, G H Jackson, G Summerfield, R J Harris, A R Pettitt, D J Allsup, J R Bailey, G Pratt, C Pepper, C Fegan, R Rosenquist, D Catovsky, J M Allan & R S Houlston, 2015, In: Leukemia. 29, 3, p. 748-751

    Research output: Contribution to journalLetter

  46. Disruption of the 5S RNP-Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia.

    Pekka Jaako, Shubhranshu Debnath, Karin Olsson, Y Zhang, Johan Flygare, M S Lindström, David Bryder & Stefan Karlsson, 2015, In: Leukemia. 29, 11, p. 2221-2229

    Research output: Contribution to journalArticle

  47. Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women - a Swedish Lymphoma Registry study.

    H R Junlén, Stefan Peterson, E Kimby, S Lockmer, Ola Lindén, H Nilsson-Ehle, M Erlanson, H Hagberg, A Rådlund, Oskar Hagberg & B E Wahlin, 2015, In: Leukemia. 29, 3, p. 668-676

    Research output: Contribution to journalArticle

  48. IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome.

    Niklas Landberg, Nils Hansen, Maria Askmyr, Helena Ågerstam, Carin Lassen, Marianne Rissler, H H Hansen, S Mustjoki, Marcus Järås, Johan Richter & Thoas Fioretos, 2015, In: Leukemia. 30, 1, p. 255-258

    Research output: Contribution to journalArticle

  49. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.

    N C P Cross, H E White, D Colomer, Hans Ehrencrona, L Foroni, E Gottardi, T Lange, T Lion, K Machova Polakova, S Dulucq, G Martinelli, E Oppliger Leibundgut, N Pallisgaard, G Barbany, T Sacha, R Talmaci, B Izzo, G Saglio, F Pane, M C Müller & 1 others, A Hochhaus, 2015, In: Leukemia. 29, 5, p. 999-1003

    Research output: Contribution to journalReview article

  50. Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia.

    Talia Velasco, Daniel Tornero Prieto & Jörg Cammenga, 2015, In: Leukemia. 29, 12, p. 2366-2374

    Research output: Contribution to journalArticle

  51. Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

    P Baliakas, A Hadzidimitriou, L-A Sutton, D Rossi, E Minga, N Villamor, M Larrayoz, J Kminkova, A Agathangelidis, Z Davis, E Tausch, E Stalika, B Kantorova, L Mansouri, L Scarfò, D Cortese, V Navrkalova, M J J Rose-Zerilli, K E Smedby, Gunnar Juliusson & 14 others, A Anagnostopoulos, A M Makris, A Navarro, J Delgado, D Oscier, C Belessi, S Stilgenbauer, P Ghia, S Pospisilova, G Gaidano, E Campo, J C Strefford, K Stamatopoulos & R Rosenquist, 2015, In: Leukemia. 29, 2, p. 329-336

    Research output: Contribution to journalArticle

  52. TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.

    A Willer, J S Jakobsen, E Ohlsson, N Rapin, J Waage, Matilda Billing, L Bullinger, Stefan Karlsson & B T Porse, 2015, In: Leukemia. 29, 5, p. 1018-1031

    Research output: Contribution to journalArticle

  53. The DEK oncoprotein and its emerging roles in gene regulation.

    Carl Sandén & Urban Gullberg, 2015, In: Leukemia. 29, 8, p. 1632-1636

    Research output: Contribution to journalReview article

Previous 1 2 3 Next